United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Cipla boosts investment in Ethris to advance mRNA therapies in emerging markets Cipla Limited has announced an additional investment of EUR 3 million in Ethris GmbH, further strengthening its involvement… byPallavi MadhirajuJune 18, 2024